| Table 1. Baseline and stimulation characteristics | |||
| Variables | Group A (GnRHa) (n=92) | Group B (hCG) (n=101) | p |
| Age (years) | 29.1±3.8 | 29.06±3.6 | 0.940 |
| Primary infertility n (%) | 54 (58.7%) | 64 (63.3%) | 0.513 |
| Secondary infertility n (%) | 38 (41.3%) | 37 (36.7%) | 0.51 |
| Duration of infertility | 6.8±2.8 | 6.2±2.3 | 0.168 |
| Irregular menstrual cycles n (%) | 45 (48.9%) | 51 (50.5%) | - |
| Clinical Hyper-androgenemia n (%) | 31 (33.7%) | 36 (35.6%) | - |
| BMI (kg/m2) | 25±3.7 | 24.9±3.8 | 0.901 |
| Day 2 FSH | 5.2±1.5 | 5.1±1.3 | 0.683 |
| AFC¥ | 26.3±4.8 | 25.1±4.5 | 0.074 |
| AMH |
5.7±2.8 | 5.9±2.6 | 0.561 |
| Dosage of gonadotrophin | 1845±707 | 2095±906 | 0.127 |
| Duration of stimulation | 10±1.2 | 10±1.4 | 0.876 |
| DFǂ≥17 | 12.7±4.3 | 10.9±2.9 | 0.001 |
| IMFῩ14-16mm | 11.7±3.9 | 9.9±3.3 | 0.001 |
| Peak Estradiol | 4678.1±1331 | 3870.4±1556 | 0.001 |
| Peak Progesterone | 1.76±1.1 | 1.39±1.1 | 0.052 |
p<0.05 = statistically significant. AFC¥-Antral follicle count; AMH£-Anti-mullerian hormone; DFǂ -Dominant follicle; IMFῩ-Intermediate follicle